Humana falls after releasing 2025 Medicare Advantage offerings

Shares of Humana (HUM) are moving lower after the company announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. “Based on member feedback, Humana is including coverage for new glasses every year in every plan with a vision benefit. Humana also is offering plans with comprehensive dental coverage that includes deep cleanings, fillings and crowns in nearly every county it serves,” the company said in a statement. Humana has a total of 793 individual Medicare Advantage plans throughout the country for 2025. Members with Part D coverage will now have a $2,000 cap on out-of-pocket drug costs, and they will no longer have a coverage gap phase. In 2025, Humana will have Medicare Advantage plan offerings in 48 states, plus Washington, D.C., and Puerto Rico, covering 89% of U.S. counties. Shares of Humana are down 6% to $297.89 in afternoon trading. Shares of Alignment Healthcare (ALHC), which also released its 2025 Medicare Advantage offerings this morning, are down 17%, or $1.99, to $9.83.